Bortezomib Waverley 1 mg powder for solution for injection
- Licence status
- Withdrawn: 04/11/2023
- Active substances
- Bortezomib
- Dosage Form
- Powder for solution for injection
- Licence number
- PA2260/001/001
- Licence holder
- Waverley Pharma Europe Limited
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- L01XX Other antineoplastic agents, L01XX32 bortezomib
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 20/03/2020